Rich traces a career that began at an ad agency and turned into 20 years in pharma, built on a single rule: never say no to the opportunity. From lobbying Congress for IVF coverage, to a lunch meeting that handed him a gene therapy launch in a therapeutic area he had never worked in, to an FDA approval that arrived by phone call with no one to celebrate with, he makes the case that the prescription is just the beginning.

Whether you’re in sales, marketing, patient services, or field reimbursement, or you’re earlier in your career and weighing a lateral move, this conversation is full of ideas you can put to work right away. The conversation dives into:

✔️ How an ad agency job turned into a 20-year career in pharma, and why Rich never says no to an opportunity

✔️ What lobbying Congress for IVF coverage taught him about patient access, years before it became his job

✔️ The FDA approval that came by phone call with no one to celebrate with, and what “let’s go to work” looked like the next day

✔️ How a team with no oncology or gene therapy experience got a first patient dosed in nine months

✔️ The four traits Rich screens for after 500 interviews: work ethic, humility, integrity, and maturity

✔️ His hot take on why pharma is too obsessed with the prescription, and where the investment needs to go instead

Hosted on Acast. See acast.com/privacy for more information.

Anand traces a career that started with a carefully written research proposal that fell apart within days of landing in Durban in 2004 — and the education that replaced it. From a missionary hospital where community health workers delivered outcomes matching, and sometimes beating, those in the United States, to a serendipitous board seat that opened the door to industry, he makes the case that community is the infrastructure and the patient runs the show.

Whether you work in medical affairs or commercialization, lead a startup, or simply want to make a bigger difference from inside a complex organization, this conversation is full of ideas you can put to work right away. The conversation dives into:

✔️ Why the smartest solutions he saw in South Africa cost almost nothing

✔️ How community and shared support drive real behavior change in chronic disease

✔️ How to bring a change-maker mindset into a big company without hitting a wall of sign-offs

✔️ His hot take on how AI will move healthcare messaging from monologue to dialogue

Hosted on Acast. See acast.com/privacy for more information.

Tinaz shares her journey — from physical therapy assistant, to launching blockbusters at Pfizer, to rebuilding at Amgen, to leading a blockbuster biosimilar launch at almost 50 with no marketing experience. Together, we unpack what resilience actually looks like in a pharma career, including:

✔️ Why failure is a prerequisite and not a red flag — "if you haven't failed, I'm not hiring you"

✔️ How stepping down to a smaller role became one of the smartest moves of her career

✔️ Why your network, not the application, is what actually opens the next door

✔️ Her three pillars — adaptable, persistent, resilient — and how to rebuild confidence after a setback

✔️ How she moved from sales into marketing at almost 50 with zero marketing experience

✔️ Her hot take: why the brutal job market is about to turn, and why AI will never replace showing up in person

Hosted on Acast. See acast.com/privacy for more information.

Margaret & George explore how patient advocacy earned its seat at the table — moving from an afterthought tucked under other departments to a strategic function that shapes reputation, trust, and access.Patty & George explore how peer-to-peer patient support is transforming clinical trial recruitment and retention, moving beyond traditional engagement strategies to create authentic connections that build trust and improve outcomes.

Whether you're at a pharmaceutical company, CRO, or patient advocacy organization, this episode will give you the insight (and inspiration) to rethink patient engagement. The conversation dives into:

✔️ How patient advocacy moved from the "kiddie table" to a seat as an equal player

✔️ What patient-centricity looks like in practice, right down to the smallest detail

✔️ Why there's a human on both sides of the patient–physician table

✔️ How simply asking for what she wanted opened doors at every stage of her career

✔️ The difference between a solo patient story and an engaged patient story — and why it decides outcomes on coverage and access

✔️ Her hot take on where patient advocacy truly belongs inside a pharma company

Hosted on Acast. See acast.com/privacy for more information.

In this episode of PatientPod, George Kramb sits down with David Craig, CEO and co-founder of Sarcomatrix, to talk about what it really takes to build in biotech, advance therapies in muscular dystrophy, and navigate the gap between scientific innovation and real-world execution.

Here's exactly what you'll learn:

✔️ Why progress in complex diseases often comes from incremental gains and combination therapies, not single breakthroughs

✔️ What the current reality of gene editing and CRISPR looks like beyond the hype

✔️ How early-stage biotech teams can align clinical, commercial, and operational strategy from the start

✔️ A practical path for aspiring founders, from building technical depth to developing real business execution

Hosted on Acast. See acast.com/privacy for more information.

In this episode of The PatientPod, George Kramb sits down with Meg Zander—a market access and U.S. policy strategy expert with 20+ years across sales, marketing, pricing, and vaccines—to unpack the career moves and mindsets that create momentum in healthcare (and how to navigate complexity without getting lost in it).

The conversation dives into:

✔️ Why commitment (especially when it’s public) is often the difference between quitting and leveling up

✔️ The “real” networking secret: build relationships before you need the ask

✔️ What Meg learned from a bold pivot from pharma to vaccines—and why some risks are worth it

✔️ How to make market access, pricing, and policy feel simple enough to act on (without oversimplifying it)

Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Patient Pod, our CEO George Kramb sits down with Quin Butler, a strategic biopharma leader with deep expertise in oncology and specialty therapies. Together, they explore the importance of patient education, prescription literacy, and healthcare system navigation—from understanding treatment options to avoiding risky medication switches. A must-listen for healthcare professionals and advocates of informed, equitable care.

Here's exactly what you'll learn:

✔️ The real reason patients struggle to access the medicine their doctor prescribes.

✔️ What patients should know before accepting a “similar, cheaper” swap at the pharmacy.

✔️ How to feel more confident navigating costs, coverage, and questions to ask.

✔️ A fresh, patient-first take on how healthcare policy really impacts care.

Hosted on Acast. See acast.com/privacy for more information.

James shares powerful lessons from his decades in MedTech — from learning how great leadership is built inside large organizations to creating global strategies that transformed startups into billion-dollar enterprises.

You’ll learn:

✔️ Why doing your current job exceptionally well opens future opportunities.

✔️ How contrarian thinking can redefine market dominance.

✔️ The evolution of leadership, innovation, and risk-taking in MedTech.

✔️ Real-world lessons from launching, scaling, and exiting multi-national healthcare ventures.

Whether you’re a healthcare founder, MedTech professional, or innovation enthusiast — this episode is packed with insight on what it takes to build enduring success in the medical device industry.

Hosted on Acast. See acast.com/privacy for more information.